Share This Author
Cognitive function across manic or hypomanic, depressed, and euthymic states in bipolar disorder.
- A. Martínez-Arán, E. Vieta, M. Salamero
- Psychology, MedicineThe American journal of psychiatry
- 1 February 2004
A poorer performance was observed in all bipolar groups regarding executive function and verbal memory in relation to the healthy comparison subjects, and cognitive difficulties, especially related to verbal memory, may help explain the impairment regarding daily functioning, even during remission.
The HCL-32: towards a self-assessment tool for hypomanic symptoms in outpatients.
Validity and reliability of the Functioning Assessment Short Test (FAST) in bipolar disorder
- A. Rosa, J. Sánchez-Moreno, E. Vieta
- Psychology, MedicineClinical practice and epidemiology in mental…
- 7 June 2007
The FAST showed strong psychometrics properties and was able to detect differences between euthymic and acute BD patients, and is a short (6 minutes) simple interview-administered instrument, which is easy to apply and requires only a short period of time to apply.
A randomized trial on the efficacy of group psychoeducation in the prophylaxis of recurrences in bipolar patients whose disease is in remission.
Group psychoeducation is an efficacious intervention to prevent recurrence in pharmacologically treated patients with bipolar I and II disorder.
Efficacy of olanzapine and olanzapine-fluoxetine combination in the treatment of bipolar I depression.
Olanzapine is more effective than placebo, and combined olanzapine-fluoxetine isMore effective than olanZapine and placebo in the treatment of bipolar I depression without increased risk of developing manic symptoms.
Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder
These 2018 CANMAT and ISBD Bipolar Treatment Guidelines represent the significant advances in the field since the last full edition was published in 2005, including updates to diagnosis and management as well as new research into pharmacological and psychological treatments.
Evidence-based guidelines for treating bipolar disorder: Revised third edition recommendations from the British Association for Psychopharmacology
The British Association for Psychopharmacology guidelines specify the scope and targets of treatment for bipolar disorder, and recommend strategies for the use of medicines in short-term treatment of episodes, relapse prevention and stopping treatment.
Cognitive impairment in euthymic bipolar patients: implications for clinical and functional outcome.
Evidence of neuropsychological impairment in euthymic bipolar patients is provided, after controlling for the effect of subsyndromal depressive symptoms, suggesting verbal memory and executive dysfunctions.
Genome-wide association study identifies 30 Loci Associated with Bipolar Disorder
The largest genome-wide association study to date, including 20,352 cases and 31,358 controls of European descent, with follow-up analysis of 881 sentinel variants at loci with P<1×10-4, achieves genome- wide significance including 18 novel loci, which provide potential new biological mechanisms for bipolar disorder.
Validation of the "World Health Organization Disability Assessment Schedule, WHODAS-2" in patients with chronic diseases
- O. Garin, J. Ayuso-Mateos, M. Ferrer
- Medicine, PsychologyHealth and quality of life outcomes
- 19 May 2010
The latent structure originally designed by WHODAS-2 developers has been confirmed for the first time, and it has shown good metric properties in clinic and rehabilitation samples, and considerable support is provided to the WHODas-2 utilization as an international instrument to measure disability based on the ICF model.